Literature DB >> 10549607

Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.

R J Griffin1, K Okajima, A Ogawa, C W Song.   

Abstract

PURPOSE: To test the individual and combined effects of local mild temperature hyperthermia (MTH) at 41.5 degrees C for 60 min and carbogen breathing on tumour radiosensitivity.
MATERIALS AND METHODS: The FSall fibrosarcoma of C3H mice and the SCK mammary carcinoma of A/J mice were used. The effect of various treatments on tumour cell survival was determined using the in vivo/in vitro tumour excision assay, and the radiobiological hypoxic fraction was calculated. The tumour radiation sensitivity was tested with the tumour growth delay assay.
RESULTS: The radiobiological hypoxic cell fraction (HF) in control FSall and SCK tumours was 0.45 and 0.78, respectively, and these values decreased to 0.12 in FSall tumours and 0.22 in SCK tumours when determined immediately after the tumours were treated with MTH. The HF was 0.32 in FSall tumours and 0.33 in SCK tumours after carbogen breathing was applied. When tumours were treated with MTH and the animals breathed carbogen the HF decreased to 0.03-0.04 in both FSall and SCK tumours. MTH treatment alone had only a small effect on tumour growth, but MTH treatment applied before irradiating the tumours significantly increased the radiation-induced tumour growth delay. Carbogen breathing modestly improved the radiation-induced tumour growth delay while the combination of MTH treatment and carbogen breathing caused the largest increase in radiation-induced tumour growth delay.
CONCLUSIONS: MTH treatment alone and combined with carbogen breathing substantially increased the tumour radiation response probably through an increase in the tumour oxygenation status.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549607     DOI: 10.1080/095530099139467

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  12 in total

1.  Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.

Authors:  S Masunaga; Y Matsumoto; G Kashino; R Hirayama; Y Liu; H Tanaka; Y Sakurai; M Suzuki; Y Kinashi; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

Authors:  Chang W Song; Yoon-Jin Lee; Robert J Griffin; Inhwan Park; Nathan A Koonce; Susanta Hui; Mi-Sook Kim; Kathryn E Dusenbery; Paul W Sperduto; L Chinsoo Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-16       Impact factor: 7.038

3.  Commentary on classic paper in hyperthermic oncology 'Tumour oxygenation is increased by hyperthermia at mild temperatures' by CW Song et al., 1996.

Authors:  Robert J Griffin; Peter M Corry
Journal:  Int J Hyperthermia       Date:  2009-03       Impact factor: 3.914

4.  Indocyanine green enhanced near-infrared laser treatment of murine mammary carcinoma.

Authors:  Gal Shafirstein; Wolfgang Bäumler; Leah J Hennings; Eric R Siegel; Ran Friedman; Mauricio A Moreno; Jessica Webber; Cassie Jackson; Robert J Griffin
Journal:  Int J Cancer       Date:  2011-07-21       Impact factor: 7.396

5.  Tumour thermotolerance, a physiological phenomenon involving vessel normalisation.

Authors:  Ruud P M Dings; Melissa L Loren; Yan Zhang; Sterling Mikkelson; Kevin H Mayo; Peter Corry; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2011-01-04       Impact factor: 3.914

Review 6.  Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.

Authors:  Robert J Griffin; Ruud P M Dings; Azemat Jamshidi-Parsian; Chang W Song
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

7.  Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Authors:  Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Tooru Kobayashi; Minoru Suzuki; Kenji Nagata; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Journal:  J Cancer Res Clin Oncol       Date:  2003-01-11       Impact factor: 4.553

8.  Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.

Authors:  R J Griffin; B W Williams; J C Bischof; M Olin; G L Johnson; B W Lee
Journal:  Technol Cancer Res Treat       Date:  2007-12

9.  Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Yoshitaka Matsumoto; Ryoichi Hirayama; Genro Kashino; Hiroki Tanaka; Minoru Suzuki; Yuko Kinashi; Yong Liu; Koichi Ando; Koji Ono
Journal:  Clin Exp Metastasis       Date:  2009-05-23       Impact factor: 5.150

10.  Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.

Authors:  S I Masunaga; K Ono; M Suzuki; Y Kinashi; M Takagaki; H Hori; S Kasai; H Nagasawa; Y Uto
Journal:  Jpn J Cancer Res       Date:  2000-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.